Patents by Inventor Julia Cuende

Julia Cuende has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TIGIT antibodies
    Patent number: 12312401
    Abstract: Anti-TIGIT antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling, plus related details, are provided on consultation of the full patent text. Combinations of these anti-TIGIT antibodies and antigen binding fragments with additional therapeutic agents, plus related details, are also provided on consultation of the full patent text. Methods for promoting T cell activity and methods of treating cancer with these anti-TIGIT antibodies and antigen binding fragments, plus related details, are provided as well on consultation of the full patent text. These methods can be applied to a human subject and details relating to this are provided on consultation of the full patent text.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 27, 2025
    Assignee: iTeos Belguim SA
    Inventors: Catherine Hoofd, Gregory Driessens, Julia Cuende
  • Anti-TIGIT Antibodies
    Publication number: 20230190931
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: July 25, 2022
    Publication date: June 22, 2023
    Applicant: iTeos Belgium SA
    Inventors: Anthony COOPER, Christophe QUEVA, Sofie DENIES, Catherine HOOFD, Julia CUENDE, Gregory DRIESSENS, Florence LAMBOLEZ
  • Anti-TIGIT Antibodies
    Publication number: 20230181731
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 15, 2023
    Applicant: iTeos Belgium SA
    Inventors: Anthony COOPER, Christophe QUEVA, Sofie DENIES, Catherine HOOFD, Julia CUENDE, Gregory DRIESSENS, Florence LAMBOLEZ
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20220306733
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: January 7, 2020
    Publication date: September 29, 2022
    Inventors: Catherine HOOFD, Gregory DRIESSENS, Julia CUENDE
  • Anti-TIGIT antibodies
    Patent number: 11439705
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: September 13, 2022
    Assignee: ITEOS BELGIUM SA
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20200407445
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: July 26, 2018
    Publication date: December 31, 2020
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20190315867
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: May 15, 2019
    Publication date: October 17, 2019
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • Anti-TIGIT antibodies
    Patent number: 10329349
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: June 25, 2019
    Assignee: iTeos Therapeutics SA
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez